Skip to main content

Table 1 Antibacterial activities (inhibition zone (IZ), cm ± SD) of crystalized and standard kojic acid from A. flavus ASU45 (OL314748) against six human pathogenic bacteria

From: Production of kojic acid by Aspergillus flavus OL314748 using box-Behnken statistical design and its antibacterial and anticancer applications using molecular docking technique

KA μg/ml

KA-Standard

KA-Crystalized

KA-Standard

KA-Crystalized

KA-Standard

KA-Crystalized

B. cereus ASU300 (IZ, cm ± SD)

S. aureus ASU301 (IZ, cm ± SD)

E. coli ASU302 (IZ, cm ± SD)

100

2.4 ± 0.1

2.75 ± 0.05

2.2 ± 0.0

2.25 ± 0.05

2.15 ± 0.05

2.35 ± 0.05

75

2.2 ± 0.0

2.55 ± 0.05

2 ± 0.1

2 ± 0.0

2 ± 0.0

2.1 ± 0.1

50

2.05 ± 0.05

2.45 ± 0.05

1.9 ± 0.0

1.95 ± 0.05

1.85 ± 0.05

1.95 ± 0.05

25

1.8 ± 0.1

2.15 ± 0.15

1.75 ± 0.05

1.85 ± 0.05

1.7 ± 0.0

1.6 ± 0.0

KA μg/ml

K. pneumonia ASU303 (IZ, cm ± SD)

S. marcescens ASU304 (IZ, cm ± SD)

S. plymuthica ASU305 (IZ, cm ± SD)

100

2.55 ± 0.05

2.85 ± 0.1

2.2 ± 0.1

2.3 ± 0.1

2 ± 0.1

2.85 ± 0.05

75

2.35 ± 0.05

2.75 ± 0.05

2.1 ± 0.0

2.1 ± 0.0

1.85 ± 0.05

2.2 ± 0.1

50

2.3 ± 0.0

2.4 ± 0.1

1.95 ± 0.05

1.95 ± 0.05

1.7 ± 0.0

1.8 ± 0.0

25

2.15 ± 0.05

2.35 ± 0.05

1.7 ± 0.0

1.75 ± 0.05

1.55 ± 0.05

1.65 ± 0.05

  1. KA kojic acid, IZ inhibition zone, SD standard deviation, Bacillus cereus ASU300, Staphylococcus aureus ASU301, Escherichia coli ASU302, Klebsiella pneumonia ASU303, Serratia marcescens ASU304, and Serratia plymuthica ASU305
Back to article page

BMC Microbiology

ISSN: 1471-2180

Contact us